Bex4 Inhibitors
Bex4 inhibitors are a class of chemical compounds designed to specifically target the Bex4 protein, a member of the brain-expressed X-linked (Bex) family. Bex proteins are known for their involvement in diverse cellular processes, including cell cycle regulation, apoptosis, and transcriptional control. Bex4, in particular, has been identified as playing a role in neural development and cellular signaling pathways. As with other members of the Bex family, Bex4 is expressed primarily in neural tissues, and its activity is linked to key intracellular processes. The inhibitors targeting Bex4 are valuable tools in molecular biology, enabling researchers to selectively modulate the activity of this protein and explore its various functional roles. These inhibitors typically act by binding to specific regions of the Bex4 protein, disrupting its normal interactions within the cell.
The design and utilization of Bex4 inhibitors allow scientists to study the structural and biochemical properties of Bex4 in a controlled manner. By inhibiting Bex4, researchers can observe changes in cellular signaling pathways and gene expression profiles, providing insight into the protein's role in maintaining cellular homeostasis. These inhibitors help clarify the mechanisms by which Bex4 influences transcriptional regulation and apoptosis, as well as its involvement in broader cellular signaling networks. Bex4 inhibitors, through their precise molecular interaction, offer a powerful means to investigate the contributions of this protein to cellular processes, particularly in the context of neural cells. As research tools, they are essential for expanding our understanding of how Bex4 operates within the broader framework of cellular and molecular biology.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This cytidine analog could hypothetically demethylate the promoter regions of genes, including Bex4, potentially leading to its transcriptional suppression due to changes in chromatin structure. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As an inhibitor of histone deacetylase, it might enhance acetylation near the Bex4 gene, which could result in tighter chromatin conformation and a subsequent decrease in Bex4 transcription. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
By inhibiting histone deacetylase activity, Suberoylanilide Hydroxamic Acid may cause hyperacetylation of histones associated with the Bex4 gene, potentially leading to transcriptional repression of this gene. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
This compound may lead to the hypomethylation of the Bex4 gene's promoter region, potentially resulting in its transcriptional repression due to alteration of DNA-protein interactions. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG 108 could prevent the methylation of CpG islands within the Bex4 promoter, potentially leading to a repression of its transcription through changes in chromatin accessibility. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
By selectively inhibiting CDK4/6, PD 0332991 could disrupt the cell cycle, potentially leading to downregulation of cell cycle-regulated genes, including possibly Bex4. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
This compound may suppress mTOR signaling, which could lead to a reduction in cap-dependent translation, potentially reducing the levels of proteins like Bex4. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
By inhibiting PI3K, LY 294002 could lead to a downregulation of the AKT signaling pathway, which may result in the decreased expression of genes such as Bex4. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
This benzoquinone ansamycin inhibits Hsp90, which may lead to the destabilization of client proteins that are essential for the maintenance of Bex4 expression, thereby reducing its levels. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Cyclopamine is known to inhibit the Hedgehog signaling pathway, which could lead to a downstream decrease in the expression of target genes, potentially including Bex4 if it is part of this pathway. | ||||||